Hawaii HB 966: RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.

Status: Referred to HLT, CPC, FIN, referral sheet 3 (as of 2023-01-30)

State: Hawaii · Session: 2023 Regular Session · Bill: HB 966

Subjects: Biological Products, Investigational Drugs, Right-to-Try Act, Terminally Ill Patients

Sponsors: AMATO, BELATTI, GANADEN, GATES, HUSSEY-BURDICK, LAMOSAO, MARTEN, MATAYOSHI, MIZUNO, NAKASHIMA, NISHIMOTO, PERRUSO, TAKENOUCHI, TARNAS, TODD, Poepoe

View Hawaii HB 966 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.